The Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly. Read More
Novo Nordisk rebrands to ‘Novo,’ CEO tells CNBC drugmaker needs to ‘rethink’ strategy amid obesity race
The Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly. Read More
